Oura is expanding its health-tracking platform with new tools designed to give deeper insights into cardiovascular health and the effects of GLP-1 medications. It comes as the popular smart ring company seeks to build momentum following its decision to shelve plans for a major stock market float.

Oura’s Health Radar and GLP-1 Insights are rolling out to members across Australia, the UK, EU, Canada, New Zealand, Mexico and Saudi Arabia, as the company pushes further into personalised health monitoring.

Wearable technology companies continue to expand beyond basic fitness tracking, using continuous biometric data to give users more detailed information about their health.

Oura’s new Health Radar tool monitors changes in biometric signals and alerts users to trends that may warrant further attention. Its latest capabilities include Blood Pressure Signals and Nighttime Breathing, which build on Oura’s existing Symptom Radar feature.

The Blood Pressure Signals feature analyses biometric data for patterns that could indicate changes in cardiovascular health. 

Nighttime BP allows users to monitor overnight blood pressure patterns. Users can also enter readings taken with a traditional blood pressure cuff into the Oura app.

Oura says the tools are intended to help users identify trends and have more informed discussions with healthcare professionals, rather than provide a medical diagnosis.

GLP-1 Insights is aimed at consumers taking GLP-1 medications used for weight management and diabetes.

The feature means users can record their medication, dosage schedules and side effects, including things like changes in appetite, nausea and energy levels. That information can then be viewed together with Oura’s measurements for sleep, activity, readiness and stress.

The company says this combined data can help users understand how medication and lifestyle changes affect their health over time.

The expansion comes at an important point for Oura and its parent company. Oura Health began preparations for a US initial public offering earlier this year, reportedly targeting a valuation of up to US$15 billion.

However, the company subsequently pulled the planned float, citing uncertainty in the IPO market. The decision came shortly after Oura had formally filed to go public.

Oura is continuing to expand its health platform and international footprint.

The new features are available to owners of Oura Ring Gen3 and newer models with an active Oura membership. This means existing customers don’t necessarily need to purchase a new ring.

The rollout also follows the introduction of the Oura Ring 5, which features redesigned sensors and a smaller profile, alongside a battery life that is claimed to last six to nine days.

The latest expansion shows Oura has ambitious plans to continue positioning it smart ring as more than just a fitness tracker. The company is increasingly using wearable data to provide personalised insights for its users across sleep, cardiovascular health, stress, activity and medication.

With a growing list of smart ring manufacturers to compete with, it’s a strategy that could prove important. Meanwhile investors will wait to see when, and if, the company will return to public markets.Â